Filing Flows › ENvue Medical (FEED) › Q1 2026 › vs Q4 2025
ENvue Medical (FEED) Q1 2026 vs Q4 2025 (quarter over quarter)
ENvue Medical's revenue rose $341K (+109%) from $312K in Q4 2025 to $653K in Q1 2026.
ENvue Medical, Q1 2026: revenue $653K (-36% year over year), operating margin -568.3%, net loss $3.8M, operating cash flow −$4.3M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $653K | $312K | $341K | +109% |
| Net loss | $3.8M | $12.9M | −$9.0M | -70% |
| Costs & expenses | $4.5M | $15.1M | −$10.7M | -70% |
| Operating costs | $4.4M | $15.1M | −$10.8M | -71% |
| Interest & other, net | $78K | −$1.5M | $1.6M | — |
| Income tax | $33K | −$419K | $452K | — |
| Cost of revenue | $708K | $682K | $26K | +4% |
| Research & development | $468K | $39K | $429K | 12× |
| Sales & marketing | $772K | $615K | $157K | +26% |
| General & admin | $2.4M | $2.6M | −$220K | -8% |
| Operating cash sources | $4.5M | $2.9M | $1.6M | +54% |
| Depreciation & amortization | $217K | $258K | −$41K | -16% |
| Cash used in operations | $4.3M | $2.7M | $1.6M | +61% |
| Net loss absorbed | $3.8M | $12.9M | −$9.0M | -70% |
| Working capital & other | $707K | −$9.9M | $10.6M | — |
Questions
How much did ENvue Medical's revenue grow quarter over quarter in Q1 2026?
ENvue Medical's revenue rose $341K (+109%) from $312K in Q4 2025 to $653K in Q1 2026.